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SUMMARY
Acute poststreptococcal glomerulonephritis (APSGN) is an inflammatory kidney condition that
can complicate Group A streptococcal infections. Two clusters of APSGN occurred recently in
New South Wales (NSW), Australia ; one in a rural town in December 1999 and the other in a
Sydney suburb in January 2000. We interviewed carers of the affected children but found no
common exposures except three of the Sydney cases were cousins in frequent contact. To assess
the probability of these clusters occurring, we analysed hospital admissions for acute
glomerulonephritis, as a proxy for APSGN in younger patients. The incidence of acute
glomerulonephritis in NSW during 1989}90–1997}8 in residents aged under 20 years was
2–2}100000}year (95% CI 2–0–2–5). Incidence was highest in children aged 5–9 years, boys and
Aboriginal children. We found no evidence for other clusters during that period. The recent
clusters highlight the continued potential for unexpected future outbreaks of APSGN.
INTRODUCTION
In late December 1999, a general practitioner reported
that he had encountered three cases of acute post-
reptococcal glomerulonephritis (APSGN) in the pre-
ceding 2 months in the same small rural town
(population approximately 2000) in the central west
of New South Wales (NSW), Australia. Subsequently,
in late January 2000, three more cases were reported,
this time in a single suburb in central Sydney. A sub-
clinical case was subsequently identified in the same
suburb.
Infections of the skin or throat by Streptococcus
pyogenes (Group A streptococcus) bacteria are com-
mon and generally uncomplicated but can sometimes
lead to potentially serious immune response-based
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complications including rheumatic fever and APSGN
[1]. In developed countries, such complications were
common up to the middle of the 20th century, but
now occur less frequently. However, they are still
relatively common in developing countries or com-
munities that experience overcrowding, poor housing
and poor hygiene [1, 2]. In Australia, rates are
particularly high in Aboriginal communities in the far
north of Australia [3, 4]. Recent evidence of an
increase in severe suppurative and immune-based
complications of streptococcal infections in developed
countries has led to growing concern about a re-
emergence of more severe Group A streptococcal
infections around the world [1, 2, 5].
APSGN is one of several forms of acute
glomerulonephritis, which is a disease in which the
glomeruli of the kidneys become inflamed, permitting
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blood and proteins to permeate into the urine. The
process by which the glomeruli become injured during
streptococcal infection is uncertain, but is believed to
be related to the body’s immune response to the
invading organism. Presenting symptoms are typical
of any form of acute nephritic syndrome: haematuria,
proteinuria, oliguria, oedema, hypertension and acute
renal failure. APSGN can be distinguished from other
forms of glomerulonephritis by evidence of recent
Group A streptococcal infection through serological
markers of streptococcal infection, and low serum C3
complement. Prognosis is generally good, with most
patients recovering completely with only supportive
therapy [6,7].
The epidemiology of APSGN in a modern, de-
veloped setting is unclear from the literature, and we
were unable to find reports of the incidence of this
condition in the general Australian population.
Further, APSGN is not a notifiable disease in NSW.
Therefore, to determine whether these clusters were
unusual in NSW, we utilized hospital admission data
as the best available source for describing the recent
epidemiology of APSGN in NSW.
METHODS
Cluster investigation
In investigating the cases, we adopted the case
definition for acute poststreptococcal glomerulo-
nephritis defined in the Northern Territory (Australia)
Health Services guidelines for APSGN (Table 1) [8].
Because APSGN can manifest as microscopic hae-
maturia without overt clinical disease [4], a sub-
clinical case was defined as criteria 2, 3 and 4 only.
Patient information was obtained from the treating
medical officers, the patient’s parents or guardians,
and medical records of the treating hospitals. Path-
ology results were obtained from medical officers and
by directly contacting the relevant pathology labora-
tories. On 1 January 2000, active surveillance was
implemented, with all 17 Area Health Service Public
Health Units across NSW being directed to canvas
paediatric units of hospitals for further suspected
cases.
Analysis of hospital admissions
We used the NSW Inpatient Statistics Collection
(ISC) [9] to extract de-identified information on
patients aged under 20 years, residing in NSW and
discharged from hospital in the period 1 July 1989 to
Table 1. Case definition for acute poststreptococcal
glomerulonephritis
Case definition
All four of the following criteria are required for a
clinical case. For a sub-clinical case, only criteria 2, 3 and
4 are required.
1. Clinically compatible illness with one or more of :
E Oedema (swelling of the face or limbs).
E Macroscopic haematuria (visibly dark urine).
E High blood pressure (diastolic" 80 mmHg if 13
years of age or younger, or " 90 mmHg if older
than 13 years).
2. Microscopic glomerular haematuria
E If urine sent to a laboratory for microscopy: red
blood cells (RBC)" 10}ml.
E If urine tested using dipstick urinalysis :
haematuria of 2› or more.
3. Eidence of recent streptococcal infection
E Positive Group A streptococcal culture from skin
or throat, or elevated serum antibodies to Group A
streptococci ; antistreptolysin O (ASO) or anti-
deoxyribonuclease B (anti-DNase B).
4. Reduced serum complement (C3) leel
30 June 1998 with a principal diagnosis of acute
glomerulonephritis. Diagnoses in the data base were
coded from the patient medical records by hospital
Health Information Managers using the International
Classification of Diseases, Revision Nine, Clinical
Modification (ICD-9-CM) [10]. Acute glomerulo-
nephritis is captured under ICD-9-CM code group
580. Although there is a more specific four digit
subcode for acute proliferative glomerulonephritis
(580.0) which includes APSGN, we included all
admissions for acute glomerulonephritis as a proxy
for APSGN. This is because there was a substantial
proportion (30%) of acute glomerulonephritis
admissions assigned a principal diagnosis of acute
glomerulonephritis of unspecified type (580.9), which
may have included cases of APSGN. This can arise
when a non-specific diagnosis, such as ‘acute
nephritis ’ is recorded on the hospital medical record
with no indication of the particular type. Further,
earlier studies have reported that APSGN accounts
for 69–91% of admitted cases of acute glomerulo-
nephritis in children [11–13]. The other four digit
sub-codes under 580 are rapidly progressive glom-
erulonephritis (580.4) and other specified acute
glomerulonephritis (580.8), which were included.
Nephrotic syndrome (581), chronic glomerulonephritis
(582), nephritis and nephropathy not specified as
being acute or chronic (583), and acute renal failure
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(584) were excluded. The ISC has been fully enum-
erated since July 1993, and partially enumerated for
some hospitals prior to July 1993. A sample weighting
factor on the data base [14] was used to estimate total
hospitalizations in those hospitals that contributed
sampled data prior to this date. However, 99% of the
acute glomerulonephritis admissions were to fully
enumerated hospitals, and therefore the influence of
sampling would be small. Interstate admissions of
NSW residents were included.
To better estimate the true population incidence of
acute glomerulonephritis leading to hospitalization,
we removed obvious multiple admissions of the same
person by deleting records with the same age in years
(to two decimal places), sex and Statistical Local Area
[15] of residence occurring within 60 days of the initial
hospitalization. The departure status of each ad-
mission episode aided in verifying multiple admissions
arising from patient transfers.
Probabilities for counts of hospital admissions for
acute glomerulonephritis were calculated assuming a
Poisson distribution of the admissions over time; for
all NSW the frequency distribution of admissions per
month was not significantly different from a theor-
etical Poisson distribution with the same average
frequency (goodness of fit : v#fl 0–16, Pfl 1–0). The
confidence intervals of crude admission rates were
calculated using the exact method for the Poisson
distribution. Confidence intervals for proportions
were calculated using the exact method for the
binomial distribution [16]. Analysis was performed
using SAS statistical software [17].
Knox’s method was applied to the hospital ad-
mission data to assess the tendency of acute glomerulo-
nephritis in NSW to cluster in time and space
(geographically) [16]. The method involves a pair-wise
comparison of each event with every other event
to determine whether each pair is adjacent in time
and}or space. In our analysis, adjacent in time was
defined as two admissions occurring 31 days or less
apart, and adjacent in space was defined as two ad-
missions occurring in residents of the same Statistical
Local Area.
RESULTS
Cluster investigation
The rural cluster consisted of two girls and a younger
boy aged 5–19 years and living in the same rural town.
All three reported preceding throat symptoms, and
none had evidence of skin sores. None of these cases
were related, or had any apparent common exposure,
except that the two younger children attended the
same school and had been swimming at the same local
pool during the week preceding their throat
symptoms. They had no contact with each other at
school. One child was admitted to hospital and the
others were treated in the outpatient department
(Table 2).
In Sydney, the cluster involved four boys aged
under 10 years living in the same suburb, three of
whom were cousins and of Polynesian background.
The first boy hospitalized was unrelated to the three
cousins, attended a different school and had no
apparent common exposure. The three cousins each
lived in separate households but played together
regularly. Only one of the Sydney cases had evidence
of a throat infection (peritonsillar abscess). The first
boy hospitalized had a preceding purulent lesion on
his arm. The three cousins had evidence of possible
skin infection related to insect bites or superficial
injury (Table 2). One case was subclinical.
Hospital admissions
There were 347 admissions for acute glomerulo-
nephritis in patients aged under 20 years between July
1989 and June 1998. Males comprised two-thirds of
the admissions in the period. Admissions were
concentrated in patients aged 5–9 years (nfl 149,
43%) (Table 3), and peaked at age 7 years (nfl 39,
11%). The number of admissions declined from 47 in
1989}90 to 35 in 1990}1, increased to 53 in 1992}3
and then declined steadily to 20 admissions in 1997}8
(Table 3). Eight percent (95% CI 5–11%) of
admissions were of people identified as being of
Aboriginal or Torres Strait Islander origin (Table 3).
This compares with only 3% of the total NSW
population aged under 20 years identifying as being
of Aboriginal or Torres Strait Islander origin in the
1996 Australian census [18]. The principal diagnosis
was proliferative glomerulonephritis (which includes
APSGN) in two-thirds and unspecified glomerulo-
nephritis in almost one-third of the admissions in
this age group (Table 3).
Admissions for acute glomerulonephritis occurred
at an average annual rate of 2–2 (95% CI 2–0–2–5) per
100000 residents aged under 20 years across NSW
over the 9-year period to June 1998. The rates in the
regions in which the clusters occurred were un-
remarkable (the rural region; Macquarie Health Area:
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Table 2. Description of cases of acute poststreptococcal glomerulonephritis according to the case definition applied
Area Health
Service
and case no.
Age
group
(years) Sex
Date of
onset of
APSGN
Clinically compatible illness Microscopic
haematuria
Red blood cells
(no.‹10’}ml)
(normally ! 10)
Recent streptococcal infection ?
Serum C3
complement (g}l)
(normally 0–83–1–70)Oedema
Visibly
dark
urine
Diastolic BP
on admission
(normally % 80)
Characteristics
and date of onset Skin swab Throat swab
ASO serology
(IU}ml)
(normally ! 200*)
Anti-DNase B
serology
(normally ! 170)
Macquarie
1 10–14 F 5 Nov 1999 No Yes 80 10–100 Throat infection
31 Oct 1999
n.d. n.d. 426 (24}11}99) ;
397 (05}12}99)
200 n.s.a.
2 15–19 F 10 Dec 1999 Yes Yes 85 10–100 Throat infection
23 Nov 1999
n.d. n.d. 858 n.d. n.s.a.
3 5–9 M 13 Dec 1999 Yes Yes 80 " 100 (14}12}99) ;
" 100 (23}12}99)
Throat infection
24 Nov 1999
n.d. n.d. 4449 (14}12}99) ;
4864 (20}12}99)
" 1600 n.s.a.
Central Sydney
1 5–9 M 8 Jan 2000 Yes Yes 87 " 100 Purulent arm lesion
25 Jan 1999
n.d. five 300 680 (12}1}00) ;
320 (13}1}00)
0–21
2 5–9 M 16 Jan 2000 Yes Yes 90 " 100 Dry knee wound}
insect bites
1 Jan 2000
n.d. five 200 680 0–16
3 5–9 M 26 Jan 2000 Yes Yes 80 " 100 Peritonsillar abscess
17 Jan 200.
n.d. five 100 (26}1}00) ;
! 100 (24}1}00)
680 0–56 (25}1}00) ;
0–45 (24}1}00)
4 0–4 M Asymptomatic No No 71 11–100 (29}1}00) ;
" 100 (31}1}00)
Insect bites 1 Jan
2000. Became wet
itchy sores
n.d. five ! 100 & 1360 0–39
BP, blood pressure ; five, no pathogens found; n.d., not done; n.s.a., no serum available; ASO, antistreptolysin O antibody to Group A streptococci titre ; anti-DNase B,
anti-deoxyribonuclease B antibody to Group A streptococci titre.
*ASO titres may be 200 or more in healthy, school-age children.
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Table 3. Characteristics of admissions (nfl 347) for acute
glomerulonephritis in patients aged under 20 years between July 1989 and
June 1998 in NSW
Characteristic}category No. % (95% CI)
Age (years)
0–4 63 18–2 (14–2–22–6)
5–9 149 42–9 (37–7–48–3)
10–14 78 22–5 (18–2–27–2)
15–19 57 16–4 (12–7–20–8)
Sex
Male 225 64–8 (59–6–69–9)
Female 122 35–2 (30–1–40–4)
Aboriginality
Non-Aboriginal 298 85–9 (81–8–89–4)
Aboriginal}Torres Strait Islander 28 8–1 (5–4–11–5)
Not stated}missing 22 6–3 (4–0–9–4)
Year of admission
1989}90 47 13–5 (10–1–17–6)
1990}1 35 10–1 (7–1–13–7)
1991}2 42 12–1 (8–9–16–0)
1992}3 53 15–3 (11–7–19–5)
1993}4 48 13–8 (10–4–17–9)
1994}5 41 11–8 (8–6–15–7)
1995}6 32 9–2 (6–4–12–8)
1996}7 29 8–4 (5–7–11–8)
1997}8 20 5–8 (3–6–8–8)
Type of acute glomerulonephritis
Proliferative (including APSGN) 227 65–4 (60–2–70–4)
Rapidly progressive 3 0–9 (0–2–2–5)
Other specified 14 4–0 (2–2–6–7)
Unspecified 103 29–7 (24–9–34–8)
Total 347 100–0
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Fig. 1. Average, minimum and maximum number of
admissions for acute poststreptococcal glomerulonephritis
in each month from July 1989 to June 1998 in persons aged
under 20 years in NSW. D, minimum; ‹, average; *,
maximum.
3–2}100000, 95% CI 1–5–5–9; inner Sydney; Central
Sydney Health Area: 2–3}100000, 95% CI 1–4–3–5).
There was no seasonal pattern of admissions evident
in NSW over the 9 years, with an average of between
2 and 5 admissions occurring in each month. There
was a maximum of 7 admissions occurring in any
January over the period, and a maximum of 5 in any
December (Fig. 1).
The clustering of cases in Sydney in January was
highly unusual ; the mean number of admissions in
January of residents of the inner Sydney region
(Central Sydney Health Area) aged under 20 years
over the 9-year period was 0–22 (95% CI 0–0–0–8).
Using the mean and its confidence limits as the
parameters of Poisson distributions, the probability of
three or more admissions in January in inner Sydney
was 0–002, with a range of 0–000–0–047. With only one
of the three cases from the rural cluster being
admitted, we were unable to determine from hospital
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admission data whether the observed cluster in that
area was unusual, although we are unaware of other
such clusters of non-hospitalized cases occurring in
NSW. For residents aged under 20 years of the central
western region of NSW (Macquarie Health Area), the
mean number of admissions in December over the
period was 0–37 (95% CI 0–09–1–04). The probability
of one or more admissions in the central west in
December was then 0–309 (0–086–0–647).
The hospital admission data did not reveal a
tendency to cluster in time and space. Over the 9
years, there were 18 pairs of patients living in the same
Statistical Local Area and admitted within 31 days of
each other, compared with 19–4 expected pairs using
Knox’s method. The probability of 18 or more pairs
occurring was 0–66.
DISCUSSION
We identified two clusters of acute glomerulonephritis
occurring around the same time but in geographically
distinct parts of NSW. The first, in late 1999, occurred
in a small rural town and involved three unrelated
children of Caucasian origin with no apparent
common exposure. The second, in early 2000, oc-
curred in an inner Sydney suburb, and involved three
related children of Polynesian origin who played
together regularly and who therefore were likely to
have a high chance of a common exposure. A fourth,
Caucasian, child in the same suburb was also affected,
but we could find no common exposure.
Analysis of hospital admission data for NSW for
the 9 years to June 1998 revealed that admissions for
acute glomerulonephritis occurred more commonly in
boys, in Aboriginal children, and around the age of
7 years. There was a declining trend in admissions in
each year since a peak in 1992}3 and no strong
seasonal pattern was evident, contrary to the New
Zealand experience where a distinct seasonal peak in
admissions occurs between April and June [19]. Based
on expected counts of admissions in the areas affected,
we were able to determine that the recent cluster of
four patients with APSGN from one suburb in Sydney
was a highly unusual event. With only one of the
recent rural cases being admitted, we could not
determine from the hospital admissions data whether
that cluster was unusual. However, analysis of state-
wide admissions data did not reveal any tendency for
acute glomerulonephritis to occur in clusters during
1989–98.
In the absence of literature describing the epi-
demiology of APSGN in modern developed settings,
the hospital admissions data provided a readily
available means by which to describe quickly its
epidemiology in NSW. The data have some
limitations, however. First, we were unable to de-
termine the epidemiology of non-admitted cases.
Second, hospital medical records are often incomplete
or unclear [20], possibly explaining why the specific
type of acute glomerulonephritis was not coded for
almost one-third of the admissions. We therefore had
to analyse all admissions coded as acute glomerulo-
nephritis as a proxy for APSGN. However, pro-
liferative glomerulonephritis, which includes APSGN,
accounted for two-thirds of the admissions. Finally,
the indigenous status of admitted patients is almost
certainly under-reported in NSW [21].
Attack rates of glomerulonephritis following Group
A streptococcal infection vary by the ability of a
particular strain of the bacteria to cause glomerulo-
nephritis (nephritogenic). Attack rates from nephrito-
genic strains of 5–43% have been reported, depending
on strain, age and site of infection [22]. A population-
based study reported an attack rate of 0–7% following
streptococcal pyoderma in African-American children
aged 2–6 years living in rural United States of America
[23]. In the first half of the twentieth century, when
APSGN was more common in developed countries,
outbreaks of the disease demonstrated a variety of
epidemiological manifestations : sporadic instances,
geographically localized clusters, clusters within
families and widespread epidemics [24]. The pro-
nounced variability in attack rates and in the
prominence of particular strains of Group A
streptococci over time [25] highlight the unpredictable
nature of these infectious agents and the potential for
further clusters of APSGN to occur in future in NSW.
At present, prophylactic antibiotic use is the only
available means of controlling Group A streptococcal
infection. Whether antibiotic treatment is protective
against progression to glomerulonephritis following
streptococcal infection is unclear, with contradictory
results reported in the literature [26, 27]. However, a
recent systematic review and meta-analysis of trials of
antibiotic treatment following sore throat showed a
trend towards being protective against glomerulo-
nephritis [28].
The Northern Territory of Australia has evidence-
based [29] recommendations for community-wide
prophylactic antibiotic use when clusters of APSGN
occur in isolated Aboriginal communities [8], a setting
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prone to epidemics probably due to high background
rates of streptococcal skin infections. Should prophy-
lactic antibiotics be recommended to prevent the
spread of APSGN when clusters occur in modern
developed urban and rural settings? Unlike the far
north of Australia, clusters of more than two cases of
APSGN are rare in both urban and rural NSW.
Furthermore, there is no evidence that further
intervention in relation to the clusters we described
would have affected further spread of APSGN. We
therefore make the following recommendations for
the public health response to clusters of APSGN in
modern developed settings such as NSW: household
contacts with overt throat or skin infection should be
treated with oral antibiotics (generally penicillin) ;
families of cases should be educated to seek medical
advice if signs or symptoms of throat or skin infection
or acute glomerulonephritis occur; clinicians should
report clusters to Public Health Units who can
investigate for common exposures to exclude possible
point sources of infection. Where ongoing risk is
identified, additional control measures may be
required.
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